
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary bioresorbable hydrogel-based formulation technology to develop transformational drug products that enhance the patient and provider experience.
© 2020 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are registered trademarks and DEXTENZA360 is a trademark of Ocular Therapeutix, Inc.
Ocular Therapeutix
24 Crosby Drive
Bedford, Massachusetts 01730